(Allergan plc)

	AGN latest price $266.1439 (-0.8%) ($263.7021 - $270.0046) on Fri. Feb. 19, 2016.
	Trend Analysis and Forecast
Average Daily Percentage Swing	1.65% (three month average)
RSI	42
Latest Price	$266.1439(-0.8%)
Stocks Behave Similarly	Similar Stock List
Daily Trend	AGN advances 0.1% a day on average for past five trading days.
Weekly Trend	AGN advances 0.3% a week on average for past two weeks.
Market Behavior	Normal for large cap. Growth stock rally for small cap.
Correlated ETFs	Broad market will support AGN advance at 0% a week (0% probability)   IBB(51%)    XLV(51%)    XBI(45%)    ARKG(42%)    SPY(41%)
Factors Impacting AGN price	AGN will decline at least -0.825% in a week (0% probabilities).   VIXM(-29%)    TLT(-17%)    UUP(-11%)    SHY(-6%)    GDXJ(-4%)
Explanation	The rally is not sustainable and not supported by the broad market.
Relative Volatility	(options are extremely cheap)
Market Trend Strength	-0.825% (StdDev 1.65%)
Hourly BBV	0 ()
Intraday Trend	-1.1%

Resistance Level	$271.22
5 Day Moving Average	$270.6(-1.65%)
10 Day Moving Average	$267.4(-0.47%)
20 Day Moving Average	$271.22(-1.87%)
To recent high	-14.5%
To recent low	3.5%
Market Cap	$87.748b

Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1984 and is headquartered in Dublin, Ireland.

getNextHourMoveProbability failed